Fickenscher James E
- SEC CIK
- 0001327442
No open-market purchases or sales filed in the past year.
Current role at each company
- ZYNE Zynerba Pharmaceuticals, Inc.Chief Financial Officeras of Oct 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fickenscher James E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Fickenscher James EChief Financial Officer | SSale | −9.00K | $1.33 | −$12.0K | −2.3%378.1K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Fickenscher James EChief Financial Officer | SSale | −17.8K | $0.60 | −$10.7K | −10.3%154.7K after | |
| Jul 20, 2022 (view filing) | Jul 19 | 1 day | Fickenscher James EChief Financial Officer | SSale | −6.01K | $1.10 | −$6.61K | −3.4%172.5K after |